.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
McKesson
Mallinckrodt
Julphar
Fish and Richardson
Medtronic
UBS
Cipla
Baxter
Johnson and Johnson

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,052,679

« Back to Dashboard

Which drugs does patent 7,052,679 protect, and when does it expire?


Patent 7,052,679 protects ADASUVE and is included in one NDA.

This patent has one hundred and ninety-five patent family members in nineteen countries.

Summary for Patent: 7,052,679

Title:Delivery of antipsychotics through an inhalation route
Abstract: The present invention relates to the delivery of antipsychotics through an inhalation route. Specifically, it relates to aerosols containing antipsychotics that are used in inhalation therapy. In a method aspect of the present invention, an antipsychotic is delivered to a patient through an inhalation route. The method comprises: a) heating a thin layer of an antipsychotic, on a solid support, to form a vapor; and, b) passing air through the heated vapor to produce aerosol particles having less than 5% antipsychotic drug degradation products. In a kit aspect of the present invention, a kit for delivering an antipsychotic through an inhalation route is provided which comprises: a) a thin film of an antipsychotic and b) a device for dispensing said thin film as a condensation aerosol.
Inventor(s): Rabinowitz; Joshua D. (Mountain View, CA), Zaffaroni; Alejandro C. (Atherton, CA)
Assignee: Alexza Pharmaceuticals, Inc. (Palo Alto, CA)
Application Number:10/767,115
Patent Claim Types:
see list of patent claims
Delivery; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Galen Uk
ADASUVE
loxapine
POWDER;INHALATION022549-001Dec 21, 2012RXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 7,052,679

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,070,765Delivery of drug esters through an inhalation route► Subscribe
7,045,118Delivery of compounds for the treatment of migraine through an inhalation route► Subscribe
7,585,493Thin-film drug delivery article and method of use► Subscribe
7,070,763Delivery of diphenhydramine through an inhalation route► Subscribe
7,537,009Method of forming an aerosol for inhalation delivery► Subscribe
6,797,259 Delivery of muscle relaxants through an inhalation route► Subscribe
7,465,436Delivery of compounds for the treatment of Parkinson's through an inhalation route► Subscribe
6,780,399 Delivery of stimulants through an inhalation route► Subscribe
7,067,114Delivery of antihistamines through an inhalation route► Subscribe
7,108,847Delivery of muscle relaxants through an inhalation route► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 7,052,679

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada2447099► Subscribe
Canada2447166► Subscribe
Canada2447210► Subscribe
Canada2447354► Subscribe
Canada2447519► Subscribe
Canada2447521► Subscribe
Canada2460343► Subscribe
Canada2462576► Subscribe
Canada2485721► Subscribe
Canada2507158► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
US Department of Justice
Fuji
Cerilliant
Cipla
AstraZeneca
Julphar
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot